Kolexia
Lambert Aurelien Oncologie médicale
Lambert Aurelien
Oncologie médicale
Institut de cancérologie de Lorraine
Vandoeuvre-lès-Nancy, France
136 Activités
4.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas COVID-19 Carcinomes Tumeurs du sein Tumeurs colorectales Tumeurs du poumon Récidive tumorale locale Carcinome épidermoïde

Collaborateurs

Voir plus
Conroy Thierry
Conroy Thierry
Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Turpin Anthony
Turpin Anthony
Hôpital Huriez, Lille, France
Bachet Jean Baptiste
Bachet Jean Baptiste
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
Advanced Accelerator Applications
16 collaboration(s)
Dernière en 2023
MSD
7 collaboration(s)
Dernière en 2023
Merck-Serono
6 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Essai Clinique (National Cancer Institute)   20 mars 2024
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery: A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Essai Clinique (National Cancer Institute)   08 mars 2024
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
CAPANCOVID-19: Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
Essai Clinique (CHU Reims)   23 janvier 2024
1e webinaire de l'UCGI sur les tumeurs neuroendocrines
Youtube @ UNICANCER - Fédération des Centres de Lutte Contre le Cancer   12 janvier 2024
Overall survival study of a 307 patients cohort treated in our institution for a gastro-intestinal cancer and undernutrition, 5 years after first inclusion
Clinical nutrition ESPEN   01 décembre 2023
IASAAC: Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients
Essai Clinique (Institut de cancérologie de Lorraine)   29 novembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023
557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
2406P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023